DAVITA INC. Financing Cash Flow
DAVITA INC. (DVA) reported Financing Cash Flow of -$483.53 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-04
- DAVITA INC. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was -$270.19M, a 6177.04% decline year-over-year.
- DAVITA INC. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$213.34M.
- DAVITA INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was -$414.52M.
- DAVITA INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was -$582.16M.
- DAVITA INC. net cash provided by (used in) financing activities for fiscal 2025 was -$1.37B.
- DAVITA INC. net cash provided by (used in) financing activities for fiscal 2024 was -$816.94M.
- DAVITA INC. net cash provided by (used in) financing activities for fiscal 2023 was -$1.17B.
- DAVITA INC. net cash provided by (used in) financing activities for fiscal 2022 was -$1.12B.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$270.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$483.53M 10-Q · filed 2026-08-04 | -$898.05M derived: sum of 3 quarters · filed 2026-08-04 | -$1.48B derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | -$213.34M 10-Q · filed 2026-05-05 | -$627.86M derived: sum of 2 quarters · filed 2026-05-05 | -$1.21B derived: sum of 3 quarters · filed 2026-05-05 | -$1.21B derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | -$414.52M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | -$996.69M derived: sum of 2 quarters · filed 2026-02-11 | -$992.24M derived: sum of 3 quarters · filed 2026-08-04 | -$1.37B 10-K · filed 2026-02-11 |
| 2025-09-30 | -$582.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | -$577.72M derived: sum of 2 quarters · filed 2026-08-04 | -$960.26M 10-Q · filed 2025-10-29 | -$1.53B derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $4.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$378.09M 10-Q · filed 2026-08-04 | -$943.20M derived: sum of 3 quarters · filed 2026-08-04 | -$951.05M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | -$382.54M 10-Q · filed 2026-05-05 | -$947.64M derived: sum of 2 quarters · filed 2026-05-05 | -$955.50M derived: sum of 3 quarters · filed 2026-05-05 | -$1.52B derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | -$565.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | -$572.96M derived: sum of 2 quarters · filed 2026-02-11 | -$1.14B derived: sum of 3 quarters · filed 2026-02-11 | -$816.94M 10-K · filed 2026-02-11 |
| 2024-09-30 | -$7.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | -$571.15M derived: sum of 2 quarters · filed 2025-10-29 | -$251.83M 10-Q · filed 2025-10-29 | -$655.08M derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-06-30 | -$563.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$243.98M 10-Q · filed 2025-08-05 | -$647.22M derived: sum of 3 quarters · filed 2026-02-11 | -$1.04B derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-03-31 | $319.32M 10-Q · filed 2025-05-12 | -$83.93M derived: sum of 2 quarters · filed 2026-02-11 | -$478.43M derived: sum of 3 quarters · filed 2026-02-11 | -$575.26M derived: sum of 4 quarters · filed 2026-02-11 |
| 2023-12-31 | -$403.25M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | -$797.75M derived: sum of 2 quarters · filed 2026-02-11 | -$894.58M derived: sum of 3 quarters · filed 2026-02-11 | -$1.17B 10-K · filed 2026-02-11 |
| 2023-09-30 | -$394.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | -$491.34M derived: sum of 2 quarters · filed 2024-10-29 | -$767.25M 10-Q · filed 2024-10-29 | -$998.15M derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-06-30 | -$96.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$372.75M 10-Q · filed 2024-08-06 | -$603.65M derived: sum of 3 quarters · filed 2025-02-13 | -$1.05B derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-03-31 | -$275.91M 10-Q · filed 2024-05-02 | -$506.81M derived: sum of 2 quarters · filed 2025-02-13 | -$952.08M derived: sum of 3 quarters · filed 2025-02-13 | -$1.06B derived: sum of 4 quarters · filed 2025-02-13 |
| 2022-12-31 | -$230.90M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | -$676.16M derived: sum of 2 quarters · filed 2025-02-13 | -$779.56M derived: sum of 3 quarters · filed 2025-02-13 | -$1.12B 10-K · filed 2025-02-13 |
| 2022-09-30 | -$445.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$548.66M derived: sum of 2 quarters · filed 2023-11-07 | -$890.23M 10-Q · filed 2023-11-07 | -$1.66B derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-06-30 | -$103.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$444.96M 10-Q · filed 2023-08-03 | -$1.22B derived: sum of 3 quarters · filed 2024-02-14 | -$1.68B derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-03-31 | -$341.57M 10-Q · filed 2023-05-08 | -$1.12B derived: sum of 2 quarters · filed 2024-02-14 | -$1.58B derived: sum of 3 quarters · filed 2024-02-14 | -$1.96B derived: sum of 4 quarters · filed 2024-02-14 |
| 2021-12-31 | -$774.36M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | -$1.24B derived: sum of 2 quarters · filed 2024-02-14 | -$1.62B derived: sum of 3 quarters · filed 2024-02-14 | -$1.08B 10-K · filed 2024-02-14 |
| 2021-09-30 | -$464.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-31 | -$845.88M derived: sum of 2 quarters · filed 2022-10-31 | -$308.60M 10-Q · filed 2022-10-31 | -$773.68M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-06-30 | -$381.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-01 | $155.55M 10-Q · filed 2022-08-01 | -$309.53M derived: sum of 3 quarters · filed 2023-02-22 | -$2.93B derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-03-31 | $537.28M 10-Q · filed 2022-05-05 | $72.20M derived: sum of 2 quarters · filed 2023-02-22 | -$2.55B derived: sum of 3 quarters · filed 2023-02-22 | -$1.41B derived: sum of 4 quarters · filed 2023-02-22 |
| 2020-12-31 | -$465.08M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | -$3.09B derived: sum of 2 quarters · filed 2023-02-22 | -$1.94B derived: sum of 3 quarters · filed 2023-02-22 | -$1.85B 10-K · filed 2023-02-22 |
| 2020-09-30 | -$2.62B derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | -$1.48B derived: sum of 2 quarters · filed 2021-10-28 | -$1.38B 10-Q · filed 2021-10-28 | -$2.07B derived: sum of 4 quarters · filed 2022-02-11 |
| 2020-06-30 | $1.14B derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $1.24B 10-Q · filed 2021-08-03 | $546.89M derived: sum of 3 quarters · filed 2022-02-11 | -$2.15B derived: sum of 4 quarters · filed 2022-02-11 |
| 2020-03-31 | $96.99M 10-Q · filed 2021-04-29 | -$595.69M derived: sum of 2 quarters · filed 2022-02-11 | -$3.29B derived: sum of 3 quarters · filed 2022-02-11 | -$4.92B derived: sum of 4 quarters · filed 2022-02-11 |
| 2019-12-31 | -$692.69M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-11 | -$3.39B derived: sum of 2 quarters · filed 2022-02-11 | -$5.02B derived: sum of 3 quarters · filed 2022-02-11 | -$4.70B 10-K · filed 2022-02-11 |
| 2019-09-30 | -$2.69B derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | -$4.33B derived: sum of 2 quarters · filed 2020-10-29 | -$4.00B 10-Q · filed 2020-10-29 | -$4.21B derived: sum of 4 quarters · filed 2021-02-12 |
| 2019-06-30 | -$1.64B derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | -$1.31B 10-Q · filed 2020-07-30 | -$1.51B derived: sum of 3 quarters · filed 2021-02-12 | -$1.63B derived: sum of 4 quarters · filed 2021-02-12 |
| 2019-03-31 | $324.95M 10-Q · filed 2020-05-05 | $122.94M derived: sum of 2 quarters · filed 2021-02-12 | $5.51M derived: sum of 3 quarters · filed 2021-02-12 | -$77.86M derived: sum of 4 quarters · filed 2021-02-12 |
| 2018-12-31 | -$202.01M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | -$319.44M derived: sum of 2 quarters · filed 2021-02-12 | -$402.81M derived: sum of 3 quarters · filed 2021-02-12 | -$625.35M 10-K · filed 2021-02-12 |
| 2018-09-30 | -$117.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$200.79M derived: sum of 2 quarters · filed 2019-11-07 | -$423.34M 10-Q · filed 2019-11-07 | -$659.76M derived: sum of 4 quarters · filed 2020-02-21 |
| 2018-06-30 | -$83.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-02 | -$305.91M 10-Q · filed 2019-08-02 | -$542.33M derived: sum of 3 quarters · filed 2020-02-21 | -$706.99M derived: sum of 4 quarters · filed 2020-02-21 |
| 2018-03-31 | -$222.55M 10-Q · filed 2019-05-07 | -$458.97M derived: sum of 2 quarters · filed 2020-02-21 | -$623.63M derived: sum of 3 quarters · filed 2020-02-21 | -$929.87M derived: sum of 4 quarters · filed 2020-02-21 |
| 2017-12-31 | -$236.43M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | -$401.08M derived: sum of 2 quarters · filed 2020-02-21 | -$707.32M derived: sum of 3 quarters · filed 2020-02-21 | -$766.26M 10-K · filed 2020-02-21 |
| 2017-09-30 | -$164.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$470.89M derived: sum of 2 quarters · filed 2018-11-07 | -$529.83M 10-Q · filed 2018-11-07 | |
| 2017-06-30 | -$306.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | -$365.18M 10-Q · filed 2018-08-01 | ||
| 2017-03-31 | -$58.94M 10-Q · filed 2018-05-03 | |||
| 2016-12-31 | -$1.35B 10-K · filed 2019-02-22 | |||
| 2015-12-31 | -$138.97M 10-K · filed 2018-02-23 | |||
| 2015-03-31 | -$110.87M 10-Q/A · filed 2015-05-08 | -$156.84M derived: sum of 2 quarters · filed 2015-05-08 | -$512.50M derived: sum of 3 quarters · filed 2015-05-08 | -$213.72M derived: sum of 4 quarters · filed 2015-05-08 |
| 2014-12-31 | -$45.97M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | -$401.63M derived: sum of 2 quarters · filed 2015-02-26 | -$102.85M derived: sum of 3 quarters · filed 2015-02-26 | -$164.98M 10-K · filed 2015-02-26 |
| 2014-09-30 | -$355.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | -$56.88M derived: sum of 2 quarters · filed 2014-11-06 | -$119.01M 10-Q · filed 2014-11-06 | -$197.78M derived: sum of 4 quarters · filed 2015-05-08 |
| 2014-06-30 | $298.77M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2014-08-01 | $236.65M 10-Q · filed 2014-08-01 | $157.88M derived: sum of 3 quarters · filed 2015-05-08 | $7.41M derived: sum of 4 quarters · filed 2015-05-08 |
| 2014-03-31 | -$62.13M 10-Q/A · filed 2015-05-08 | -$140.89M derived: sum of 2 quarters · filed 2015-05-08 | -$291.37M derived: sum of 3 quarters · filed 2015-05-08 | -$477.72M derived: sum of 4 quarters · filed 2015-05-08 |
| 2013-12-31 | -$78.77M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | -$229.24M derived: sum of 2 quarters · filed 2015-02-26 | -$415.60M derived: sum of 3 quarters · filed 2015-02-26 | -$482.99M 10-K · filed 2015-02-26 |
| 2013-09-30 | -$150.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | -$336.83M derived: sum of 2 quarters · filed 2014-11-06 | -$404.22M 10-Q · filed 2014-11-06 | $3.59B derived: sum of 4 quarters · filed 2015-02-26 |
| 2013-06-30 | -$186.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-01 | -$253.75M 10-Q · filed 2014-08-01 | $3.74B derived: sum of 3 quarters · filed 2015-02-26 | $3.69B derived: sum of 4 quarters · filed 2015-02-26 |
| 2013-03-31 | -$67.39M 10-Q · filed 2014-05-02 | $3.93B derived: sum of 2 quarters · filed 2015-02-26 | $3.87B derived: sum of 3 quarters · filed 2015-02-26 | $3.85B derived: sum of 4 quarters · filed 2015-02-26 |
| 2012-12-31 | $4.00B derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | $3.94B derived: sum of 2 quarters · filed 2015-02-26 | $3.92B derived: sum of 3 quarters · filed 2015-02-26 | $3.87B 10-K · filed 2015-02-26 |
| 2012-09-30 | -$58.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06 | -$82.80M derived: sum of 2 quarters · filed 2013-11-06 | -$125.46M 10-Q · filed 2013-11-06 | -$157.35M derived: sum of 4 quarters · filed 2014-02-21 |
| 2012-06-30 | -$24.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | -$66.97M 10-Q · filed 2013-08-07 | -$98.86M derived: sum of 3 quarters · filed 2014-02-21 | $41.78M derived: sum of 4 quarters · filed 2014-02-21 |
| 2012-03-31 | -$42.66M 10-Q · filed 2013-05-09 | -$74.55M derived: sum of 2 quarters · filed 2014-02-21 | $66.09M derived: sum of 3 quarters · filed 2014-02-21 | -$251.34M derived: sum of 4 quarters · filed 2014-02-21 |
| 2011-12-31 | -$31.89M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-21 | $108.75M derived: sum of 2 quarters · filed 2014-02-21 | -$208.68M derived: sum of 3 quarters · filed 2014-02-21 | -$247.18M 10-K · filed 2014-02-21 |
| 2011-09-30 | $140.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-31 | -$176.79M derived: sum of 2 quarters · filed 2012-10-31 | -$215.29M 10-Q · filed 2012-10-31 | $141.03M derived: sum of 4 quarters · filed 2013-03-01 |
| 2011-06-30 | -$317.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-03 | -$355.93M 10-Q · filed 2012-08-03 | $392.00K derived: sum of 3 quarters · filed 2013-03-01 | -$85.61M derived: sum of 4 quarters · filed 2013-03-01 |
| 2011-03-31 | -$38.50M 10-Q · filed 2012-05-02 | $317.82M derived: sum of 2 quarters · filed 2013-03-01 | $231.81M derived: sum of 3 quarters · filed 2013-03-01 | -$99.06M derived: sum of 4 quarters · filed 2013-03-01 |
| 2010-12-31 | $356.32M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | $270.31M derived: sum of 2 quarters · filed 2013-03-01 | -$60.56M derived: sum of 3 quarters · filed 2013-03-01 | -$82.39M 10-K · filed 2013-03-01 |
| 2010-09-30 | -$86.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | -$416.88M derived: sum of 2 quarters · filed 2011-11-04 | -$438.71M 10-Q · filed 2011-11-04 | -$536.21M derived: sum of 4 quarters · filed 2012-07-06 |
| 2010-06-30 | -$330.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-04 | -$352.71M 10-Q · filed 2011-08-04 | -$450.21M derived: sum of 3 quarters · filed 2012-07-06 | -$491.75M derived: sum of 4 quarters · filed 2012-07-06 |
| 2010-03-31 | -$21.83M 10-Q · filed 2011-05-06 | -$119.33M derived: sum of 2 quarters · filed 2012-07-06 | -$160.88M derived: sum of 3 quarters · filed 2012-07-06 | -$173.12M derived: sum of 4 quarters · filed 2012-07-06 |
| 2009-12-31 | -$97.50M derived: 8-K 12 month − 10-Q 9 month · filed 2012-07-06 | -$139.04M derived: sum of 2 quarters · filed 2012-07-06 | -$151.29M derived: sum of 3 quarters · filed 2012-07-06 | -$192.07M 8-K · filed 2012-07-06 |
| 2009-09-30 | -$41.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-05 | -$53.79M derived: sum of 2 quarters · filed 2010-11-05 | -$94.57M 10-Q · filed 2010-11-05 | -$168.92M derived: sum of 4 quarters · filed 2011-02-25 |
| 2009-06-30 | -$12.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-05 | -$53.03M 10-Q · filed 2010-08-05 | -$127.37M derived: sum of 3 quarters · filed 2011-02-25 | -$117.68M derived: sum of 4 quarters · filed 2011-02-25 |
| 2009-03-31 | -$40.78M 10-Q · filed 2010-05-03 | -$115.13M derived: sum of 2 quarters · filed 2011-02-25 | -$105.44M derived: sum of 3 quarters · filed 2011-02-25 | |
| 2008-12-31 | -$74.34M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-25 | -$64.65M derived: sum of 2 quarters · filed 2011-02-25 | -$252.13M 10-K · filed 2011-02-25 | |
| 2008-09-30 | $9.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2009-11-05 | -$177.78M 10-Q · filed 2009-11-05 | ||
| 2008-06-30 | -$187.47M 10-Q · filed 2009-08-07 | |||
| 2007-12-31 | $2.52M 10-K · filed 2010-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |